Bristol-Myers Squibb (BMY) Dividend Yield & History

BMY$63.43+1.11 +1.78%
Drug Manufacturers - GeneralLarge CapValue StockHigh Quality
Compare
Market cap$129.66BEnterprise value$166.45BRevenue (TTM)$50.03BMarket positionTop 25%

Score

61
Neutral
Value
64
Quality
72
Growth
47
$63.43Price
$129.66BMarket cap
14.03P/E
9.84Forward P/E
3.97%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

A past-year dividend of $2.52 a share gives Bristol-Myers Squibb Company a 3.97% yield at $63.43.

Bristol-Myers Squibb raised its yearly dividend every year from 2009 to 2025.

The 2 January 2026 increase took the Bristol-Myers Squibb quarterly dividend from $0.62 to $0.63, up 1.6%.

Last year the Bristol-Myers Squibb dividend was 55% of earnings.

Bristol-Myers Squibb pays a dividend every quarter.

The next ex-dividend date for Bristol-Myers Squibb hasn't been announced yet.

The Bristol-Myers Squibb dividend compounded at 6.6% a year over five years.

Our records cover 217 payments from 1972 to 2026.

At today's yield, $10,000 invested would receive about $397 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full BMY quote · Forecast · Academy

Questions

When did BMY last raise the dividend?

The increase was $0.62 to $0.63, dated 2 January 2026.

How often does BMY pay a dividend?

Quarterly payments, 4 of them in the past year.

How many years has BMY raised the dividend?

In 5 of the last 5 years. 2025 totalled $2.48 a share.

What is the BMY dividend yield?

3.97% is the Bristol-Myers Squibb yield.

Bristol-Myers Squibb (BMY) Dividend Yield & History

BMY price $63.43 +1.11 +1.78%

Ticker
BMY
Price
$63.43
Change
+1.11 +1.78%
Market cap
$129.66B
P/E
14.03
Forward P/E
9.84
Dividend yield
3.93%
Beta
0.23
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
61
Value
64
Quality
72
Growth
47

Stocklytics score rationale: value 64, quality 72, growth 47.

AI Score 75. Bristol-Myers Squibb has a strong market cap of $127.71 billion and a solid net profit margin of approximately 18.5%, indicating good profitability. However, its high price-to-earnings ratio of about 13.82 and a price-to-book ratio of 5.45 suggest that it may be overvalued relative to its earnings and assets, which could limit upside potential

Summary

Bristol-Myers Squibb Company operates in Healthcare, within the Drug Manufacturers - General industry. Its overall score is 59.

Valuation

The shares have a P/E of 13.8 and a price-to-book ratio of 5.5. The value score is 64.

Quality

The quality score is 67, supported by a net margin of 18.5%. The dividend yield is 4.0%.

Growth

The growth score is 46, indicating growth is the weakest of the reported factor scores.

Risks

Growth is a relative concern given the growth score of 46. The price-to-book ratio of 5.5 may also be relevant when assessing valuation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener